Loading company…
Singleron, trading name of Xingeyuan Biotechnology, makes single-cell multi-omics tools and sequencing services.
Based in Nanjing, China and founded in 2018, Singleron (Xingeyuan Biotechnology Co., Ltd.) develops molecular diagnostic products and automation equipment. The company focuses on single-cell multi-omics analysis for drug development, scientific research and genomics. CEO Nan Fang holds a PhD in Immunology, and the company employs more than 400 people, 24 of whom have PhDs. It plans to use its Series B funding for global commercialization of its single-cell multi-omics platform.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in